FDA Inspection 1238509 — Hikma Pharmaceuticals USA INC.
The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on January 17, 2025 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 17, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbus, OH (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)